Events

At least 2 million Americans a year contract an antibiotic-resistant infection, the Centers for Disease Control and Prevention reports. So, what can the U.S. do to safeguard public health amid the growing threat of these superbugs? Tune in to a live webcast as Dr. Scott Gottlieb, commissioner of the U.S. Food and Drug Administration, announces […]

The AMR Challenge encourages global leaders to make formal commitments that further progress against antimicrobial resistance. Your efforts could contribute to solutions that protect humans, animals, and the environment from this global threat. The first batch of commitments will be unveiled at a United Nations (UN) General Assembly side event on September 25, and will […]

Helping Antibacterial Development to Move Forward - New discovery platforms, novel screens and approaches are vital for the discovery of new antibacterials and for ceasing the dangerous trend of multidrug microbial resistance. Cambridge Healthtech Institute's 5th Annual Antibacterial Discovery and Development track will focus on the general, strategic issues and solutions that would allow new […]

The Grand Challenges Annual Meeting aims to accelerate the translation of innovation to impact to address the world’s most urgent global health and development problems. The meeting is a forum for researchers to share their work, learn about cutting-edge advances in the field and build collaborations with other investigators and organizations.  This year the meeting […]

Kevin Outterson to present

At the 4th Annual World Anti-Microbial Resistance Congress, over 400 stakeholders will gather in Washington D.C. to discuss critical challenges and opportunities to advance antibiotic and diagnostics development, improve antimicrobial stewardship practice and incentivize funding and partnering to bring innovation to patients and the healthcare system in need.  Discussions will be addressing 4 key areas: Antibiotic R&D, Diagnostics, Antimicrobial […]

The Biomedical Advanced Research and Development Authority (BARDA), a component of the U.S. Department of Health and Human Services Administration for Strategic Preparedness and Response (ASPR), invites you to participate in our annual conference at which you can learn about U.S. Government medical countermeasure priorities, interact with BARDA and ASPR staff, and network with public […]

Antimicrobial resistance is an increasingly serious threat to global public health that requires action across all government sectors and society. BioInfect will look at the critical issues relating to the development of new anti-infectives and the endemic problem of resistance.   Dr. Richard Lawson, CARB-X Senior Project Manager, will be delivering the keynote address.

Kevin Outterson is the N Neal Pike Professor of Health and Disability Law at Boston University and the Executive Director of CARB-X, the world’s largest product development partnership addressing drug-resistant bacterial infections. He will share his personal stories of how experiences, skills, passion and faith converge in the efforts to protect us all from drug-resistant bacterial infections.

The All-Party Parliamentary Group on Antibiotics APPG-A exists to raise the profile of antibiotic resistance, the need to preserve antibiotics through education on their appropriate use including non‐human uses, the lack of new treatments for bacterial infections and to help accelerate efforts to discover, research and develop new treatments. The British Society for Antimicrobial Chemotherapy serves as Secretariat […]